CFTR and cystic fibrosis: In this study, the authors observed that airway inflammation in PwCF treated with ETI was not eliminated but rather returned to the non-CF bronchiectasis range, supporting the concept that for PwCF with established lung disease, restoration of CFTR results in disease modification and a phenotype shift rather than a definitive cure [98].